首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1029篇
  免费   119篇
  国内免费   3篇
林业   97篇
农学   31篇
基础科学   11篇
  218篇
综合类   103篇
农作物   41篇
水产渔业   46篇
畜牧兽医   519篇
园艺   13篇
植物保护   72篇
  2023年   5篇
  2022年   6篇
  2021年   13篇
  2020年   17篇
  2019年   17篇
  2018年   29篇
  2017年   17篇
  2016年   25篇
  2015年   30篇
  2014年   43篇
  2013年   55篇
  2012年   59篇
  2011年   89篇
  2010年   50篇
  2009年   40篇
  2008年   70篇
  2007年   67篇
  2006年   68篇
  2005年   57篇
  2004年   59篇
  2003年   60篇
  2002年   64篇
  2001年   16篇
  2000年   16篇
  1999年   13篇
  1998年   11篇
  1997年   11篇
  1996年   3篇
  1995年   3篇
  1994年   7篇
  1993年   8篇
  1992年   11篇
  1991年   4篇
  1990年   6篇
  1989年   17篇
  1987年   4篇
  1986年   6篇
  1985年   4篇
  1984年   7篇
  1983年   3篇
  1982年   5篇
  1981年   3篇
  1980年   7篇
  1979年   3篇
  1977年   8篇
  1975年   3篇
  1973年   2篇
  1971年   5篇
  1970年   6篇
  1968年   4篇
排序方式: 共有1151条查询结果,搜索用时 140 毫秒
21.
1. Nitrogen-corrected apparent and true metabolisable energy contents (AMEN and TMEN) of 12 diets, containing different amounts of maize, wheat, barley and rye, barley with beta-glucanase and maize with 0.05 g/kg guar gum were measured using 3-week-old male broilers. 2. The AMEN method involved: 4 d of dietary adaptation, 24 h of starvation, 54 h of ad libitum feeding, 24 h of starvation and daily total droppings collection. TMEN was measured after a 48 h starvation period followed by 2 d of tube-feeding two doses of 15 g of the diets and quantitatively collecting all the droppings after 48 h of starvation. The endogenous energy losses (EELN) were measured after tube-feeding 8 chickens with 30 g of glucose, also over 2 d. 3. The results show that a significant interaction exists between the nature of the diets and the method used to measure metabolisable energy. Differences between TMEN and AMEN values ranged from 1.03 to 1.98 MJ/kg dry matter. These differences were positively correlated with the total pentosan contents of the diet (r = 0.94), the natural logarithm of the viscosities of the water extracts (r = 0.87), the sum of the contents of total pentosans and total beta-glucan (r = 0.85), the calculated total non-starch polysaccharide contents (r = 0.79), the neutral detergent fibre contents (r = 0.76) and the total beta-glucan contents (r = 0.70). Furthermore, a significant interaction was found between diets and the method used to derive lipid digestibility. The differences between apparent and true lipid digestibility ranged from 0.05 percentage points for the wheat diet to 0.20 percentage points for the rye diet. 4. From the results of this trial, it appears that TMEN overestimates the energy value of high fibre diets.  相似文献   
22.
OBJECTIVE: To evaluate whether immunosuppressive doses of cyclosporine (CsA) have an adverse effect on the liver, kidney, and pancreatic beta cells of pigs. ANIMALS: 8 juvenile 8-week-old Landrace X Large White crossbred pigs. PROCEDURE: CsA (100 to 140 mg/kg) was administered orally to euglycemic pigs to reach whole blood trough concentrations of approximately 1500 ng/mL. To determine pancreatic beta cell function, plasma C-peptide and insulin concentrations were measured in response to i.v. administration of glucose, glucagon, arginine, and oral administration of glucose. Effects on liver and kidney were determined by monitoring serum measurements of liver function and serum creatinine concentrations, respectively. RESULTS: Plasma concentrations of C-peptide were significantly lower in euglycemic CsA-treated pigs, compared with control pigs, following i.v. administration of glucose, glucagon, arginine, and oral administration of glucose. Furthermore, the glucose clearance rate was decreased in euglycemic CsA-treated pigs, compared with control pigs. Serum creatinine concentrations and 4 of 7 serum measurements of liver function were not adversely affected by CsA administration. Serum concentrations of bilirubin and albumin were significantly increased, and serum alanine aminotransferase activity was significantly decreased in CsA-treated pigs, compared with control pigs. Histologic evaluation of liver and kidney sections revealed no pathologic findings in CsA-treated or control pigs. CONCLUSIONS AND CLINICAL RELEVANCE: In our study, immunosuppressive doses of CsA caused an impairment of porcine pancreatic beta cell function, but did not have toxic effects on the kidney. However, on the basis of changes in serum bilirubin and albumin concentrations and alanine aminotransferase activity, subclinical toxic effects on the liver did occur when immunosuppressive doses of CsA were administered.  相似文献   
23.
OBJECTIVE: To determine whether hematologic and serum biochemical values for blood samples obtained from cats via vascular access ports (VAP) are comparable to those for samples obtained by direct venipuncture. DESIGN: Prospective study. ANIMALS: 14 healthy cats. PROCEDURE: A VAP was surgically implanted in a jugular vein in each cat. Blood samples were obtained from the VAP and by direct venipuncture of the contralateral jugular vein 10 weeks after VAP placement. Results of hematologic and serum biochemical analyses were compared by use of a paired t-test. The Pvalue to reject the null hypothesis was adjusted to account for multiple comparisons by using the Bonferroni procedure in which the nominal P-to-reject value is divided by the number of comparisons (0.05/24 = 0.002). RESULTS: Paired samples (VAP and venipuncture) obtained 10 weeks after VAP placement were evaluated for each cat. Of the 24 measured analytes, only potassium, total protein, and albumin concentrations differed significantly (P< 0.001 for all 3) between VAP and venipuncture samples. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that samples obtained from VAP are suitable for routine hematologic monitoring of feline cancer patients. Sample hemolysis may account for a slight increase in potassium, total protein, and albumin concentrations obtained from VAP samples. However, the values of variables most critical for monitoring of patients receiving chemotherapy (ie, mature neutrophil and platelet counts) are comparable. If proper techniques are used, VAP may be used for administration of chemotherapy as well as for blood collection in cats undergoing cancer treatment.  相似文献   
24.
25.
26.
27.
ABSTRACT Spatial and temporal distribution of Maize streak virus (MSV, family Geminiviridae, genus Mastrevirus) was monitored in the vector species Cicadulina mbila and the nonvector species C. china? using conventional and real-time quantitative polymerase chain reaction. Sustained feeding on MSV-infected plants showed that virus accumulation reaches a maximum in C. china?, but not in C. mbila. After a 3-day acquisition access feeding period (AAP), MSV was detected in the gut, the hemolymph, and the head of C. mbila, but only in the gut of C. china?. Similarly, Digitaria streak virus (genus Mastrevirus), which is not transmitted by either of the two species, was only detected in the gut. MSV was detected in the hemolymph of C. mbila 3 h after the beginning of the AAP. Although viral DNA progressively decreases in the vector and nonvector species after a 3-day AAP, MSV DNA remained stable in the salivary glands of C. mbila.  相似文献   
28.
Canine parvoviral enteritis continues to cause significant morbidity and mortality in dogs worldwide, and efficacious antiviral therapies are lacking. The present trial was aimed at evaluating the therapeutic efficacy of a recombinant feline interferon (type omega) preparation in the treatment of parvoviral enteritis in dogs. A double-blind, placebo-controlled challenge trial was performed in beagle pups (8-9 weeks); clinical signs, body weight, hematologic parameters, and mortality were monitored for a period of 14 days after challenge. Fourteen animals were inoculated with virulent canine parvovirus; 10 animals that developed clinical signs thereby meeting the inclusion criteria were admitted to the treatment phase in two randomly selected groups (placebo and IFN) of equal size. The IFN group received daily intravenous injections of rFeIFN-omega (2.5 MU/kg) for three consecutive days. The placebo group received daily injections of saline without IFN. Both groups of animals received individual supportive treatment consisting of adjusted diet and electrolyte solution.All five dogs in the placebo group developed fulminating enteritis with typical clinical signs and died within 10 days post-inoculation (or 6 days post-treatment). In the IFN-treated group, one animal died on day 2 after the treatment was started, whereas the other four dogs survived the challenge and gradually recovered. Our data confirm that the rFeIFN-omega can exert a significant therapeutic effect on dogs with parvoviral enteritis by improving clinical signs and reducing mortality.  相似文献   
29.
Ethoxylates of rapeseed oil and of methylated rapeseed oil were synthesized and tested as adjuvants for 2,4-D and phenmedipham. Provided they had less than 6 units of ethylene oxide (EO), 1.0 to 10 g litre(-1) ethoxylates in water induced droplet spreading on barley leaves. In an acetone-based medium all derivatives strongly promoted the foliar uptake of 2,4-D, with no clear influence of the ethoxylation degree. In the same medium there was a negative influence of ethoxylate chain length on the foliar uptake of phenmedipham. In a water-based medium, phenmedipham applied with rapeseed oil emulsified with ethoxylated (20 EO) rapeseed oil displayed uptake rates close to a commercial preparation. The same was true for phenmedipham applied with ethoxylated (2 EO) methylated rapeseed oil. In bioassays, phenmedipham prepared with methylated rapeseed oil emulsified with ethoxylated (20 EO) rapeseed oil was as efficacious on barley as a commercial formulation. The same was true for phenmedipham prepared with ethoxylated (2 EO) methylated rapeseed oil. However, neither rapeseed oil nor methylated rapeseed oil emulsified with ethoxylated (2 EO) methylated rapeseed oil conferred good efficacy to phenmedipham. Hence, ethoxylated rapeseed oil derivatives are promising adjuvants or formulants for herbicides.  相似文献   
30.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号